350 related articles for article (PubMed ID: 24492837)
1. Cancer Systems Biology: a peek into the future of patient care?
Werner HM; Mills GB; Ram PT
Nat Rev Clin Oncol; 2014 Mar; 11(3):167-76. PubMed ID: 24492837
[TBL] [Abstract][Full Text] [Related]
2. Future of personalized medicine in oncology: a systems biology approach.
Gonzalez-Angulo AM; Hennessy BT; Mills GB
J Clin Oncol; 2010 Jun; 28(16):2777-83. PubMed ID: 20406928
[TBL] [Abstract][Full Text] [Related]
3. Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering.
Joo JI; Choi M; Jang SH; Choi S; Park SM; Shin D; Cho KH
Adv Mater; 2020 Sep; 32(35):e1906783. PubMed ID: 32253807
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine driven by cancer systems biology.
Filipp FV
Cancer Metastasis Rev; 2017 Mar; 36(1):91-108. PubMed ID: 28265786
[TBL] [Abstract][Full Text] [Related]
5. Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.
Coyle KM; Boudreau JE; Marcato P
Biomed Res Int; 2017; 2017():9620870. PubMed ID: 28685150
[TBL] [Abstract][Full Text] [Related]
6. A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.
Yurkovich JT; Tian Q; Price ND; Hood L
Nat Rev Clin Oncol; 2020 Mar; 17(3):183-194. PubMed ID: 31619755
[TBL] [Abstract][Full Text] [Related]
7. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies.
Du W; Elemento O
Oncogene; 2015 Jun; 34(25):3215-25. PubMed ID: 25220419
[TBL] [Abstract][Full Text] [Related]
8. Navigating cancer network attractors for tumor-specific therapy.
Creixell P; Schoof EM; Erler JT; Linding R
Nat Biotechnol; 2012 Sep; 30(9):842-8. PubMed ID: 22965061
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.
Tian Q; Price ND; Hood L
J Intern Med; 2012 Feb; 271(2):111-21. PubMed ID: 22142401
[TBL] [Abstract][Full Text] [Related]
11. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
Yeang CH; Beckman RA
Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
[TBL] [Abstract][Full Text] [Related]
12. Between pathways and networks lies context: implications for precision medicine.
Laderas T; Wu G; McWeeney S
Sci Prog; 2015; 98(Pt 3):253-63. PubMed ID: 26601340
[TBL] [Abstract][Full Text] [Related]
13. Circumventing cancer drug resistance in the era of personalized medicine.
Garraway LA; Jänne PA
Cancer Discov; 2012 Mar; 2(3):214-26. PubMed ID: 22585993
[TBL] [Abstract][Full Text] [Related]
14. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
Tsimberidou AM; Ringborg U; Schilsky RL
Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic.
Stricker T; Catenacci DV; Seiwert TY
Semin Oncol; 2011 Apr; 38(2):173-85. PubMed ID: 21421108
[TBL] [Abstract][Full Text] [Related]
16. Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
Beckman RA; Schemmann GS; Yeang CH
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14586-91. PubMed ID: 22891318
[TBL] [Abstract][Full Text] [Related]
17. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
18. Revolutionizing medicine in the 21st century through systems approaches.
Hood L; Balling R; Auffray C
Biotechnol J; 2012 Aug; 7(8):992-1001. PubMed ID: 22815171
[TBL] [Abstract][Full Text] [Related]
19. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
20. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]